0001831601-20-000001.txt : 20201106 0001831601-20-000001.hdr.sgml : 20201106 20201106135839 ACCESSION NUMBER: 0001831601-20-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20201106 DATE AS OF CHANGE: 20201106 EFFECTIVENESS DATE: 20201106 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Advanced Chemotherapy Technologies, Inc. CENTRAL INDEX KEY: 0001831601 IRS NUMBER: 471550292 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-379953 FILM NUMBER: 201293706 BUSINESS ADDRESS: STREET 1: 2301 STONEHENGE DRIVE STREET 2: SUITE 204 CITY: RALEIGH STATE: NC ZIP: 27615 BUSINESS PHONE: 919-917-7324 MAIL ADDRESS: STREET 1: 2301 STONEHENGE DRIVE STREET 2: SUITE 204 CITY: RALEIGH STATE: NC ZIP: 27615 D 1 primary_doc.xml X0708 D LIVE 0001831601 Advanced Chemotherapy Technologies, Inc. 2301 STONEHENGE DRIVE SUITE 204 RALEIGH NC NORTH CAROLINA 27615 919-917-7324 DELAWARE None None Corporation true Anthony S. Voiers 2301 Stonehenge Drive Suite 204 Raleigh NC NORTH CAROLINA 27615 Executive Officer Director Promoter Jen Jen Yeh 2301 Stonehenge Drive Suite 204 Raleigh NC NORTH CAROLINA 27615 Director Joseph DeSimone 2301 Stonehenge Drive Suite 204 Raleigh NC NORTH CAROLINA 27615 Director Biotechnology Decline to Disclose 06b false 2020-10-23 false true false 0 14100000 5499993 8600007 false 1 0 0 0 true Proceeds will be used for working capital, which may include normal compensation to executive officers. false Advanced Chemotherapy Technologies, Inc. Anthony S. Voiers Anthony S. Voiers CEO 2020-11-04